The report is designed to serve a wide audience, including investors, startups, established enterprises, consultants, and policymakers. Each group can use the insights provided to achieve different objectives, whether it is identifying investment opportunities, entering new markets, or improving existing operations. This broad applicability makes the research a valuable tool for decision-makers across industries.

The Companion Animal Health Market is expected to grow from an estimated USD 23.5 billion in 2025 to USD 53.2 billion in 2035, at a CAGR of 9.50%.

The most significant driver of the companion animal health market is pet ownership that is increasing rapidly globally, especially in the developed and developing countries. For instance, according to the European Pet Food Industry Federation, in 2021, 46% of the households in Europe owned pets. This shows the way in which society considers pets as part of its family.

Additionally, as per the American Veterinary Medical Association, pet ownership has been slowly increasing in the US for the past several decades and is currently estimated at nearly 67% of the families having at least one animal. This is certainly not an exclusive Western pattern. Rapid urbanisation along with increasing disposable incomes has fuelled a huge surge in pet adoption and care all over Asia-Pacific. The rising middle class and cultural changes in China and India have increased the number of veterinary visits as well as pet health expenses.

Moreover, government policies are also very significant. For the safety and efficacy of veterinary drugs and vaccines, regulatory bodies like the European Food Safety Authority (EFSA) and the U.S. Department of Agriculture (USDA) are actively regulating them. Preventive healthcare encourages owners to spend money on diagnosis and treatment.

Moreover, awareness about zoonotic diseases and government vaccination drives indirectly encourage market growth. However, there is data to support the validity of these drivers. As the CDC has stated that 60% of new infectious diseases emerging worldwide have zoonotic origins, the case for veterinary health systems has been supported in this way.

Preventive care visits to clinics have increased by 15-20% during the last decade, according to veterinary groups, which demonstrates increasing interest in animal welfare. This contributes to a growing companion animal health market, increased pet ownership, and awareness, as well as encouraging government initiatives.

For instance, government-sponsored immunization programs, pet health education efforts, and other collaborative activities involving the organizations and the authorities themselves in response to the increasing demand are some examples.

For businesses aiming to succeed in today’s fast-paced environment, access to reliable market insights is one of the most valuable assets. Companies must continuously evaluate their strategies, understand customer preferences, and respond to changing market conditions. To support this need, Emergen Research has introduced its latest Companion Animal Health market research content, offering a comprehensive and structured approach to market analysis.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4443

Competitive landscape:-

A key highlight of the Companion Animal Health market research content is its detailed analysis of the competitive landscape. The report provides a clear overview of major companies operating in the market, along with their strategies and recent developments. By examining activities such as mergers, acquisitions, partnerships, and product innovations, businesses can gain a better understanding of how the competitive environment is evolving.

Advancements in Veterinary Diagnostics and Treatments Boost the Market Growth

This growth in the Companion Animal Health Market is attributed to technology advancements in veterinary diagnostics and treatments. These innovations have transformed the way diseases are diagnosed and managed, making them more efficient and reliable in pet healthcare. Diagnostic tools such as molecular imaging, portable ultrasound devices, and advanced blood tests have made it possible for veterinarians to identify health issues much earlier, thus improving treatment outcomes.

Governments and organisations have played a great role in promoting these innovations. For instance, the United States Department of Agriculture (USDA) actively finances research on advanced veterinary technologies. In like manner, the European Medicines Agency (EMA) has licensed several veterinary vaccines and treatments that provide safe and effective disease prevention for companion animals. These regulatory approvals help build trust among pet owners and veterinarians to encourage the general adoption of these advanced solutions.

According to AVMA, modern diagnostic applications in veterinary practice have gone up by nearly 25 per cent within the last five years in North America. That indicates the use of increased reliance on technology in offering pets better healthcare services. Veterinary institutions in Europe reported that digital imaging and other portable diagnostic tools are taken up more nowadays, largely with government funding initiatives in support.

In addition, the partnership between veterinary institutions and technology companies has expanded the scope of available treatments. For instance, veterinary vaccines are now widely used to treat specific diseases, such as Lyme disease and canine parvovirus, which have resulted in a lower mortality rate among pets. Such progress underscores how technological advancement and institutional support drive the growth of the Companion Animal Health Market.

Market segmentation:-

In addition to competitive analysis, the report offers an in-depth segmentation of the market. By breaking down the Companion Animal Health market into different categories, businesses can identify specific areas of growth and tailor their strategies accordingly. This segmentation provides insights into demand patterns, production levels, and consumption trends, helping organizations make more informed decisions.

The Companion Animal Health Market features intense competition from players with a complete product portfolio, including well-established brands like Zoetis Inc., Merck Animal Health, and Elanco Animal Health. The small players in the Asia-Pacific region are gaining momentum based on cost-effective and novel solutions. Supported by technological improvements and pet health awareness, the market is expected to grow at a very good rate. Increasing investments in R&D and strategic collaborations will further enhance market competitiveness and global expansion.

In June 2025, Merck Animal Health, a division of Merck & Co., Inc., launched the NOBIVAC NXT Rabies portfolio in Canada. This new line of rabies vaccines, utilising advanced RNA-particle technology, provides enhanced protection for cats and dogs against rabies. The portfolio includes NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies, reflecting Merck's ongoing commitment to innovative pet healthcare solutions.

Some of the key companies in the global Companion Animal Health Market include:

• Agrolabo S.p.A.
• Boehringer Ingelheim International GmbH
• Ceva
• Elanco
• IDEXX Laboratories, Inc.
• Indian Immunologicals Ltd.
• Merck & Co., Inc.
• Norbrook
• Vetoquinol
• Virbac
• Zoetis Services LLC

The Companion Animal Health market research content is built on a foundation of advanced research methodologies and expert analysis. Emergen Research combines data from multiple sources to ensure accuracy and reliability. The content includes detailed reports, case studies, whitepapers, and trend analyses that cover a wide range of industries.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/companion-animal-health-market

Another important feature of the report is its focus on actionable recommendations. Instead of presenting data in isolation, the research provides practical suggestions that businesses can implement to improve their performance. These recommendations are tailored to different industries and address specific challenges faced by organizations.

The report also emphasizes the importance of staying updated with the latest market trends. Emergen Research regularly updates its content to reflect new developments, ensuring that businesses always have access to current information. This helps organizations stay competitive and respond effectively to changes in the market.

Furthermore, the inclusion of expert insights adds significant value to the research. The analysts behind the report have extensive experience and a deep understanding of industry dynamics. Their perspectives help businesses interpret data more effectively and make informed decisions.

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/4443

Emergen Research’s commitment to quality and accuracy makes it a trusted partner for businesses seeking reliable market intelligence. The company’s research is designed to provide a complete understanding of the market, helping organizations identify opportunities and achieve sustainable growth.

About Emergen Research
Emergen Research is a global provider of market research and consulting services, offering a wide range of solutions to help businesses succeed. With expertise across multiple industries, the company delivers accurate and actionable insights that support strategic decision-making.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com